Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005

This study has been completed.
Sponsor:
Information provided by:
Hillerod Hospital, Denmark
ClinicalTrials.gov Identifier:
NCT01176305
First received: August 5, 2010
Last updated: NA
Last verified: October 2009
History: No changes posted
  Purpose

The purpose of this study is to describe the incidence of thromboembolic events in relation to pregnancy and when in pregnancy and the puerperal period.


Condition
Venous Thromboembolism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005

Resource links provided by NLM:


Further study details as provided by Hillerod Hospital, Denmark:

Primary Outcome Measures:
  • Absolute incidence of thromboembolic event

Groups/Cohorts
Danish Women 15 to 49 years old.
Free of previous VTE and current use of oral contraceptives.

Detailed Description:

Venous thromboembolism (VTE) still causes maternal death in the western world. The purpose of this study is to estimate the relative and absolute risk of VTE at different gestational ages in pregnant women compared to non-pregnant women.

All Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives are included.Non-pregnant women are controls.

  Eligibility

Ages Eligible for Study:   15 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives.

Criteria

Inclusion Criteria:

  • Danish woman at 15 to 49 years old in the period January 1995 through December 2005.
  • Free of previous VTE and current use of oral contraceptives.

Exclusion Criteria:

  • Previous VTE or current use of oral contraceptives.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Thomas Bergholt, Hillerod Hospital, Gynecolocical-Obstetrical department
ClinicalTrials.gov Identifier: NCT01176305     History of Changes
Other Study ID Numbers: RAV1
Study First Received: August 5, 2010
Last Updated: August 5, 2010
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Keywords provided by Hillerod Hospital, Denmark:
Thromboembolic event

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Cardiovascular Diseases
Embolism and Thrombosis
Thrombosis
Vascular Diseases

ClinicalTrials.gov processed this record on October 22, 2014